Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting

Maryza Graham; Stephen Muhi; Tuyet Hoang; Susan A Ballard; Julie McAuley; Jason C Kwong; Deborah A Williamson; Benjamin P Howden; COVID-19 Diagnostics Research Group

doi:10.1016/j.pathol.2021.07.002

Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting

Pathology. 2021 Dec;53(7):912-914. doi: 10.1016/j.pathol.2021.07.002. Epub 2021 Sep 4.

Authors

Maryza Graham¹, Stephen Muhi², Tuyet Hoang³, Susan A Ballard³, Julie McAuley⁴, Jason C Kwong⁵, Deborah A Williamson⁶, Benjamin P Howden⁷; COVID-19 Diagnostics Research Group

Affiliations

¹ Microbiological Diagnostic Unit Public Health Laboratory, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia; Department of Microbiology and Infectious Diseases, Monash Health, Clayton, Vic, Australia. Electronic address: maryza.graham@monashhealth.org.
² Microbiological Diagnostic Unit Public Health Laboratory, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia; Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Vic, Australia.
³ Microbiological Diagnostic Unit Public Health Laboratory, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia.
⁴ Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia.
⁵ Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia; Department of Infectious Diseases, Austin Hospital, Heidelberg, Vic, Australia.
⁶ Microbiological Diagnostic Unit Public Health Laboratory, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia; Department of Microbiology, Royal Melbourne Hospital, Melbourne, Vic, Australia.
⁷ Microbiological Diagnostic Unit Public Health Laboratory, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia; Department of Infectious Diseases, Austin Hospital, Heidelberg, Vic, Australia.

No abstract available

Publication types

Letter

MeSH terms

Australia / epidemiology
COVID-19 / diagnosis*
COVID-19 / epidemiology*
COVID-19 / prevention & control
COVID-19 / virology
COVID-19 Testing / instrumentation*
COVID-19 Testing / methods*
Diagnostic Tests, Routine
Evaluation Studies as Topic
Humans
Molecular Diagnostic Techniques / methods*
Nucleic Acid Amplification Techniques / methods
Pandemics
Point-of-Care Systems / standards*
Prevalence
SARS-CoV-2 / genetics*
SARS-CoV-2 / isolation & purification*
Sensitivity and Specificity